Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Research & Development (2019 - 2025)

Korro Bio's Research & Development history spans 7 years, with the latest figure at $11.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development fell 35.24% year-over-year to $11.0 million, compared with a TTM value of $65.6 million through Dec 2025, up 3.05%, and an annual FY2025 reading of $65.6 million, up 3.05% over the prior year.
  • Research & Development for Q4 2025 was $11.0 million at Korro Bio, down from $13.8 million in the prior quarter.
  • The five-year high for Research & Development was $21.0 million in Q2 2025, with the low at -$39.3 million in Q4 2023.
  • Average Research & Development over 5 years is $11.7 million, with a median of $13.9 million recorded in 2023.
  • Year-over-year, Research & Development tumbled 1245.92% in 2023 and then skyrocketed 143.13% in 2024.
  • Tracing KRRO's Research & Development over 5 years: stood at $12.8 million in 2021, then plummeted by 73.09% to $3.4 million in 2022, then tumbled by 1245.92% to -$39.3 million in 2023, then skyrocketed by 143.13% to $17.0 million in 2024, then plummeted by 35.24% to $11.0 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Research & Development are $11.0 million (Q4 2025), $13.8 million (Q3 2025), and $21.0 million (Q2 2025).